Showing results (81-90 of 464) with videos related to

Sort By:
Pageof 47
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2000
Second allogeneic transplantation after failure of first autologous transplantationJ P Radich, T Gooley, J E Sanders, et al.
Bone Marrow Transplantation|June 12, 2002
The use of radioimmunoconjugates in stem cell transplantationJ M Pagel, D C Matthews, F R Appelbaum, et al.
International Journal of Cell Cloning|January 1, 1986
Selection of patients with Hodgkin's disease and non-Hodgkin's lymphoma for bone marrow transplantationK M Sullivan, F R Appelbaum, S J Horning, et al.
Schweizerische Medizinische Wochenschrift|December 9, 1978
[Long-term, complete remission in non-Hodgkin's lymphoma following high-dosage combination therapy with or without autologous bone marrow transplantation]A A Gratwohl, F R Appelbaum, A S Levine, et al.
Leukemia Research|January 16, 2003
Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpressionD L Stirewalt, F R Appelbaum, C L Willman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasiaR P Witherspoon, H J Deeg, B Storer, et al.
Current Opinion in Hematology|November 1, 1996
The role of radioimmunotherapy in bone marrow transplantationM C Corcoran, O W Press, D C Matthews, et al.
Transplantation|July 1, 1986
Cure of malignant lymphoma in dogs with peripheral blood stem cell transplantationF R Appelbaum, H J Deeg, R Storb, et al.
British Journal of Haematology|November 1, 1987
Does histologic grading of inflammation in bone marrow predict the response of aplastic anaemia patients to antithymocyte globulin therapy?G E Sale, J Rajantie, K Doney, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1988
Toxicity trial of prophylactic 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine (ganciclovir) after marrow transplantation in dogsF R Appelbaum, J D Meyers, H J Deeg, et al.
Pageof 47